Why It Matters

Enabling Confident Decisions at Every Stage of the Therapeutic Lifecycle

Leaders can make confident decisions when data, workflows and analytics are connected from discovery through manufacturing. This reduces risk, shortens development timelines and delivers more substantial returns while helping bring new therapies to patients more quickly.

AI-powered and machine learning (ML) image analysis speeds up discovery and decision-making. It aids target identification, phenotypic screening, spatial profiling and biomarker research. By combining high-content imaging and deep visual proteomics with advanced analytics, researchers can gain deeper biological insights faster, with better reproducibility and scalability.

The life sciences companies of Danaher support these applications with our advanced AI/ML portfolio of solutions. Contact one of our experts to learn how we can help you generate insights.

Enhancing Imaging Value

High-content imaging and deep visual proteomics provide insights into biological mechanisms during drug response and translational research studies. However, drawing clear conclusions or identifying patterns during analysis can sometimes be challenging.

AI/ML image analysis tools offer several benefits:

Boost confidence and efficiency by speeding up processing times

Help clarify biological mechanisms

Assist in detecting phenotypic changes

Reduce subjectivity and minimize risk

Danaher Corporation

Driving Actionable Insights

Danaher Corporation

Danaher Corporation

We see a way to reduce time from raw image to fully analyzed data by up to 74%.

Leica Microsystems | Aivia AI Image Analysis Software

Learn More

Danaher Corporation

Danaher Corporation

We see a way to accelerate High Content Imaging 4X and enable AI-generated analysis.

Molecular Devices | IN Carta Image Analysis Software

Learn More

Danaher Corporation

Danaher Corporation

We see a way to increase assay sensitivity by 50% using AI-based phenotypic classification.

Genedata | Genedata Screener

Learn More

Danaher Corporation

Videos

Danaher Corporation

Innovative AI Software Solutions Driving Biomarker Research Efficiency

Learning Objectives:

Quickly and accurately segment cells using AI so you can spend less time analyzing data and more time on the biology; Leverage your expertise or automation to classify cells into different phenotypes and interactively explore them in their spatial context

Watch now

Danaher Corporation

Transforming High-Content Screening with Intelligent Imaging and AI Analysis

Learning Objectives:

Master essential high-content imaging assays from 2D phenotypic profiling to 3D imaging using patient-derived organoids; Explore the power of AI-driven analysis with IN Carta software to tackle the most challenging screening assays

Watch now

Danaher Corporation

Learn how AstraZeneca Automates Image Analysis with Deep Learning

Learning Objectives:

Learn how automated workflows enable scalable deep learning for image analysis without requiring machine learning expertise; See how deep learning-based approaches can increase mechanistic insight and assay sensitivity, in a cardiac safety profiling case study

Watch now

Additional Resources

Leica Microsystems

What’s new with AIVIA 15

Product Flyer

Download

FAQs

What is AI-driven image analysis and how does it work in life sciences?

AI-driven image analysis utilizes sophisticated algorithms to examine microscopic images and extract valuable insights. In life sciences, it aids in understanding complex cellular mechanisms and processes relevant to translational research, drug discovery and development.

How does AI improve accuracy and efficiency in image analysis?

AI enhances accuracy and efficiency by eliminating the subjectivity found in manual analysis. Additionally, it assists in detecting patterns that might otherwise remain hidden or unnoticed through basic analysis.

Which imaging types can AI analyze?

AI can analyze all types of images, from brightfield to confocal images. It can also be used for nanoscale imaging, like electron transmission microscopy.

How does AI accelerate drug discovery and research?

AI is accelerating drug discovery and research in several ways. It helps with target identification, unlocks complex cellular behaviors in cell-based assays, decodes spatial dynamics in tissue samples and can even help repurpose or design new drugs.

What should be considered when using AI in regulated labs?

Concerns vary by laboratory type, but key considerations include data security, regulatory compliance, algorithm performance and validation, documentation, audit trails and addressing ethical issues related to its use.

Find Out More

id
TTAE
name
TTAE
_clientID
546005641
_deExternalKey
TTAE
_action
add
_returnXML
1
Inquiry_Type
Talk to an Expert
_successURL
https://lifesciences.danaher.com/us/en/connect/thank-you.html
_errorURL
https://help.salesforce.com/s/articleView?id=sf.mc\_es\_demanager.htm